Download Files:
Solanezumab
$300 – $1,250
Products Details
Product Description
– Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1].
Web ID
– HY-P99317
Storage Temperature
– Store at -80°C for 2 years
Shipping
– Dry Ice
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– N/A
References
– [1][1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease. N Engl J Med. 2018 Jan 25;378(4):321-330.
CAS Number
– 955085-14-0
Molecular Weight
– 144.1 (kDa)
Compound Purity
– 95.00
SMILES
– [Solanezumab]
Clinical Information
– Phase 3
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Amyloid-β
Pathway
– Neuronal Signaling
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
